Privi Speciality Chemicals Limited announced that its Board of Directors, in a meeting held on December 19, 2025, approved a Scheme of Amalgamation. The scheme involves the amalgamation of its wholly-owned subsidiaries, Privi Fine Sciences Private Limited (PFSPL) and Privi Biotechnologies Private Limited (PBPL), with the parent company, Privi Speciality Chemicals Limited (PSCL). This amalgamation is being carried out under Sections 230 to 232 of the Companies Act, 2013, and is subject to approvals from shareholders, creditors, the National Company Law Tribunal (NCLT), and other relevant regulatory authorities. PFSPL operates a manufacturing unit in Lote, Maharashtra, and has acquired land in Jhagadia, Gujarat, for its 'green science' business, currently at a pilot testing phase. PBPL is engaged in the research and development of biotechnology products and processes, including applications in fragrances, flavors, and preservatives. The rationale behind the amalgamation is to strengthen PSCL's business by enhancing operational capabilities, market competitiveness, and expanding its product offerings and customer base. It is expected to lead to optimum use of infrastructure, cost reduction, efficiency gains, and logistic advantages, thereby contributing to future growth and maximizing shareholder value. The integration aims to leverage combined assets, capabilities, expertise, and infrastructure, creating an integrated value chain and improving financial and debt management. Under the scheme, no cash consideration will be paid. Shareholders of PFSPL will receive 1 (one) equity share of PSCL (₹10 face value) for every 135 (one hundred and thirty-five) equity shares of PFSPL (₹10 face value). The equity shares of PBPL held by PSCL will be cancelled without issuing new shares of PSCL. The transaction is considered a related party transaction, but it is being conducted on an arm's length basis, supported by a valuation report from M/s. RBSA Valuation Advisors LLP and a fairness opinion from Vivro Financial Services Private Limited. The amalgamation is anticipated to simplify management structures, reduce administrative and operational costs, and create a stronger base for future growth.